Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 37813959

Long-term, continuous infusion of single-agent dinutuximab beta for relapsed/refractory neuroblastoma: an open-label, single-arm, Phase 2 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Br J Cancer
Publication date
2023 Nov
First author
Lode HN

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Lode HN
      type
      Author
    2. name
      Ehlert K
      type
      Author
    3. name
      Huber S
      type
      Author
    4. name
      Troschke-Meurer S
      type
      Author
    5. name
      Siebert N
      type
      Author
    6. name
      Zumpe M
      type
      Author
    7. name
      Loibner H
      type
      Author
    8. name
      Ladenstein R
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Lode HN
      type
      Author
    2. name
      Ehlert K
      type
      Author
    3. name
      Huber S
      type
      Author
    4. name
      Troschke-Meurer S
      type
      Author
    5. name
      Siebert N
      type
      Author
    6. name
      Zumpe M
      type
      Author
    7. name
      Loibner H
      type
      Author
    8. name
      Ladenstein R
      type
      Author
    bibliography ids
    1. nci-bib-2868d0d933148f162eeb318f
    book metadata
    content sha256
    c9372c98fbe3aa679f65a5ed8da5bbb71213611f8df3ba7a0cfdefc52e34e9ba
    document type
    citation
    dois
    1. 10.1038/s41416-023-02457-x
    electronic publication date
    display
    2023 Oct 10
    precision
    day
    year
    2023
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:37813959
    immutable id
    pubmed:37813959@c9372c98fbe3aa679f65a5ed8da5bbb71213611f8df3ba7a0cfdefc52e34e9ba
    journal
    abbreviation
    Br J Cancer
    issn electronic
    1532-1827
    issn print
    0007-0920
    issue
    11
    name
    British journal of cancer
    nlm unique id
    0370635
    pages
    1780-1786
    volume
    129
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      37813959
      provenance
      batch id
      5329a5d0877ee70ecd11
      provider
      NCBI PubMed ESummary
      record sha256
      0c2af48ed308c37a4e06c81c25efa1b98e350aba5cdd2c78c2a176bccff80c6f
      response sha256
      bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
      retrieved at
      2026-09-09T23:48:15.763286+00:00
      publication date
      display
      2023 Nov
      precision
      month
      year
      2023
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/37813959/
      title
      Long-term, continuous infusion of single-agent dinutuximab beta for relapsed/refractory neuroblastoma: an open-label, single-arm, Phase 2 study.

      Preserved source evidence · Not medical advice